C12N 9/6445
Kallikreins
Official title: {Kallikreins (3.4.21.34; 3.4.21.35)}
C12N9/6445 (Kallikreins) appears on 148 US grants and 173 published applications in this corpus.
Search patents in C12N- Granted patents
- 148
- Published applications
- 173
- Assignees
- 109
- Inventors
- 402
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 8 | 0 |
| 2000 | 10 | 0 |
| 2001 | 9 | 2 |
| 2002 | 6 | 9 |
| 2003 | 0 | 11 |
| 2004 | 1 | 11 |
| 2005 | 1 | 6 |
| 2006 | 6 | 8 |
| 2007 | 5 | 6 |
| 2008 | 1 | 12 |
| 2009 | 5 | 8 |
| 2010 | 8 | 4 |
| 2011 | 5 | 4 |
| 2012 | 5 | 6 |
| 2013 | 4 | 6 |
| 2014 | 1 | 2 |
| 2015 | 4 | 3 |
| 2016 | 4 | 7 |
| 2017 | 5 | 9 |
| 2018 | 6 | 10 |
| 2019 | 9 | 12 |
| 2020 | 3 | 6 |
| 2021 | 5 | 8 |
| 2022 | 4 | 9 |
| 2023 | 4 | 3 |
| 2024 | 7 | 5 |
| 2025 | 2 | 5 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Prostate antigen standards and uses thereof30 Dec 2025US 12,510,543 B2OPKO Diagnostics, LLC
- Methods to spatially profile protease activity in tissue and sections3 Jun 2025US 12,320,801 B2Massachusetts Institute of Technology
- Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers31 Dec 2024US 12,180,259 B2Immatics Biotechnologies GmbH
- Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers19 Nov 2024US 12,144,852 B2Immatics Biotechnologies GmbH
- Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers1 Oct 2024US 12,102,670 B2Immatics Biotechnologies GmbH
- Compositions targeting klkb1 and methods of use thereof13 Aug 2026US 2026/0232843 A1Poseida Therapeutics, Inc.
- Intravenous compositions of tissue kallikrein-1 and related methods16 Oct 2025US 2025/0319167 A1
- Anti-klk4 antibodies and uses thereof26 Jun 2025US 2025/0206846 A1Yeda Research and Development Co. Ltd.
- Sample preparation for glycoproteomic analysis that includes diagnosis of disease12 Jun 2025US 2025/0189534 A1
- Underglycosylated kallikrein i, and polyethylene glycol modifier thereof and pharmaceutical use thereof9 Jan 2025US 2025/0011747 A1Zonhon Biopharma Institute Inc.
Most cited
By later US patents
- Database for storage and analysis of full-length sequences121US 6,303,297 B1Incyte Pharmaceuticals, Inc. · 2001
- Pasteurized therapeutically active protein compositions78US 4,440,679 ACutter Laboratories, Inc. · 1984
- Tissue specific viral vectors57US 5,698,443 ACalydon, Inc. · 1997
- Pasteurized therapeutically active protein compositions53US 4,623,717 AMiles Laboratories, Inc. · 1986
- Polynucleotides encoding a novel prostate-specific kallikrein50US 5,786,148 AIncyte Pharmaceuticals, Inc. · 1998